- Exchange: OTC BB
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Health Care Supplies
Aethlon Medical Inc
+ Add to WatchlistAEMD:US
0.0950 USD 0.0150 13.64%As of 20:10:00 ET on 06/18/2013.
Snapshot for Aethlon Medical Inc (AEMD)
| Open: | 0.1080 | Day's Range: | 0.0950 - 0.1100 | Volume: | 728,019 |
|---|---|---|---|---|---|
| Previous Close: | 0.1100 | 52wk Range: | 0.0600 - 0.1500 | 1-Yr Rtn: | +5.56% |
Key Statistics for AEMD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0600 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 15.97 |
| Shares Outstanding (M) | 168.08 |
| 30 Day Average Volume | 223,095 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 9.8529 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AEMD
Company Profile & Key Executives for AEMD
Aethlon Medical, Inc. develops medical devices which treat infectious diseases. The Company's products include the Hemopurifier, which provides treatment against drug and vaccine resistant bioweapons, naturally evolving pandemic threats such as H5N1 Avian Flu, and chronic infectious disease targets including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV).
| James A Joyce "Jim"Chairman/CEO/Secretary | Rodney S Kenley "Rod"President |
| James B FrakesCFO/Senior VP:Finance | Richard H TullisVP/Chief Science Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AEMD News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page